GlassScriptPhysician profile
Jeffrey Livingston
NPI 1396744330
$4,854.19
in general payments reported to CMS, 2019-2025
19 companies · $849 in 2025
The $849 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $1,316 · 2021: $480 · 2022: $424 · 2023: $416 · 2024: $1,255 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,981 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $506 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $505.80 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,373.18 | 2020-2025 | |
| Medical Device Business Services, INC. | $920.59 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $752.30 | 2019-2025 | Dupixent |
| Smith+Nephew, INC. | $529.39 | 2021-2024 | Birmingham Hip, Tula |
| Acclarent, INC | $414.66 | 2019-2024 | Trudi Nav Cable |
| Glaxosmithkline, LLC. | $152.51 | 2022-2025 | Nucala |
| Optinose US, INC. | $120.08 | 2019-2025 | |
| Amgen INC. | $102.42 | 2025 | Tezspire |
| Neurent Medical Limited | $76.83 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Stryker Corporation | $65.36 | 2020-2025 | Audion Et Dilation System |
| Aerin Medical INC. | $64.67 | 2019-2025 | |
| Boston Scientific Corporation | $64.38 | 2025 | Watchman Flx |
| Intersect Ent, INC. | $62.66 | 2019-2022 | |
| Medtronic, INC. | $59.73 | 2022-2024 | Propel |
| Integra Lifesciences Corporation | $27.05 | 2024 | Acclarent Aera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.94 | 2022 | |
| Hologic Sales and Service, LLC | $19.18 | 2022 | |
| Icu Medical INC | $16.67 | 2024 | Tracheostomy |
| Alk-Abello, INC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Livingston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.